Top

Published in:

01-09-2014 | Review

Current status of extracorporeal ventricular assist devices in Japan

Author: Takashi Nishimura

Published in: Journal of Artificial Organs | Issue 3/2014

Abstract

Extracorporeal VADs are less expensive, their prices reimbursable by the health insurance being about one-sixth of those of implantable VADs in Japan. However, a disadvantage is that, in Japan, their use is restricted to hospitals, necessitating prolonged hospitalization, reducing the patients’ quality of life. According to the Japanese registry for Mechanically Assisted Circulatory Support, the survival rate does not differ significantly between patients with extracorporeal and implantable VADs. As in Europe and North America, extracorporeal VADs in Japan are commonly used as Bridge to Decision or Bridge to Recovery. Extracorporeal VADs are switched to implantable VADs as a Bridge-to-Bridge strategy after stabilization or when cardiac function recovery fails. They are also used as right ventricular assist devices (RVADs) in patients with right heart failure. A special characteristic of extracorporeal VADs in Japan is their frequent use as a Bridge to Candidacy. In Japan, indications for implantable VADs are restricted to patients registered for heart transplantation. Therefore, in patients who cannot be registered for transplantation because of transient renal dysfunction, etc., due to heart failure, extracorporeal VADs are used first, and then replaced by implantable VADs after transplant registry is done. Here, we describe the current status of extracorporeal VADs in Japan, focusing on the environmental backgrounds, along with a review of the relevant literature.

Pharmaceuticals and Medical Devices Agency. J-MACS information (updated 9 April 2014). http://www.info.pmda.go.jp/kyoten_kiki/track.html.

Furuta S, Wanibuchi T, Ito T, Kyo S, Urushikubo K, Kaneko K, Koike K, Takeda M, Kano T, Ono T, Atsumi K, Fujimasa I, Imachi K, Miyake H, Takido N, Nakajima M. The first clinical experience of the circulatory assistance using the partial artificial heart. Jpn J Artif Organs. 1981;1:657–60.

Sato N, Mohri H, Sezai Y, Koyanagi H, Fujimasa I, Imachi K, Atsumi K, Nitta S, Miura M. Multi-institutional evaluation of the Tokyo University ventricular assist system. ASAIO Trans. 1990;36:M708–11.PubMed

Japanese Association for Clinical ventricular assist systems. Registry 2012 (updated 9 April 2014). http://plaza.umin.ac.jp/~jacvas/VAS_registry2012.pdf.

Takano H, Nakatani T, Taenaka Y, Kitoh Y, Hiramori K, Haze K, Itoh A, Fujita T, Manabe H. Treatment of acute profound heart failure by ventricular assist device. Jpn Circ J. 1992;56:100–10.CrossRefPubMed

Takano H, Taenaka Y, Noda H, Kinoshita M, Yagura A, Tatsumi E, Sekii H, Sasaki E, Umezu M, Nakatani T, Kyo S, Omoto R, Akutsu T, Manabe H. Multi-institutional studies of the National Cardiovascular Center ventricular assist system: use in 92 patients. ASAIO Trans. 1989;35:541–4.CrossRefPubMed

Hayashi K, Matsuda T, Takani H, Umezu M, Taenaka Y, Nakamura T. Effects of implantation on the mechanical properties of the polyurethane diaphragm of left ventricular assist devices. Biomaterials. 1985;6:82–8.CrossRefPubMed

Kimura M, Nishimura T, Kinoshita O, Kashiwa K, Kyo S, Ono M. Hemodynamic influence of tilting disc valve type on pump performance with the NIPRO: ventricular assist device. J Artif Organs. 2012;15:134–9.CrossRefPubMed

Kashiwa K, Nishimura T, Nakahara A, Momose N, Umeda C, Kubo H, Takami H, Kinugawa K, Adachi H, Yamaguchi A, Yambe T, Katogi T, Kyo S, Ono M. Survey of blood pump diaphragm damage in the NIPRO: ventricular assist device. J Artif Organs. 2012;15:341–6.CrossRefPubMed

10.

Ono M, Nishimura T, Kinoshita O, Shiga T, Kinugawa K, Nagai R, Kyo S. Improved survival in patients with continuous-flow ventricular assist device for bridge to heart transplantation. Transplant Proc. 2013;45:2017–8.CrossRefPubMed

11.

Saito S, Matsumiya G, Sakaguchi T, Fujita T, Kuratani T, Ichikawa H, Sawa Y. Fifteen-year experience with Toyobo paracorporeal left ventricular assist system. J Artif Organs. 2009;12:27–34.CrossRefPubMed

12.

Sasaoka T, Kato TS, Komamura K, Takahashi A, Nakajima I, Oda N, Hanatani A, Mano A, Asakura M, Hashimura K, Niwaya K, Funatsu T, Kobayashi J, Kitamura S, Shishido T, Wada K, Miyata S, Nakatani T, Isobe M, Kitakaze M. Improved long-term performance of pulsatile extracorporeal left ventricular assist device. J Cardiol. 2010;56:220–8.CrossRefPubMed

13.

Pharmaceuticals and Medical Devices Agency. J-MACS Statistical Report (updated April 9, 2014). http://www.info.pmda.go.jp/kyoten_kiki/file/J-MACS_Statistical_Report201309.pdf.

14.

Morgan JA, Stewart AS, Lee BJ, Oz MC, Naka Y. Role of the Abiomed BVS 5000 device for short-term support and bridge to transplantation. ASAIO J. 2004;50:360–3.PubMed

15.

Worku B, Naka Y, Pak SW, Cheema FH, Siddiqui OT, Jain J, Uriel N, Bhatt R, Colombo P, Jorde U, Takayama H. Predictors of mortality after short-term ventricular assist device placement. Ann Thorac Surg. 2011;92:1608–13.CrossRefPubMed

16.

Samuels LE, Holmes EC, Garwood P, Ferdinand F. Initial experience with the Abiomed AB5000 ventricular assist device system. Ann Thorac Surg. 2005;80:309–12.CrossRefPubMed

17.

Zhang L, Kapetanakis EI, Cooke RH, Sweet LC, Boyce SW. Bi-ventricular circulatory support with the Abiomed AB5000 System in a patient with idiopathic refractory ventricular fibrillation. Ann Thorac Surg. 2007;83:298–300.CrossRefPubMed

18.

Conradi L, Schirmer J, Reiter B, Treede H, Kubik M, Reichenspurner HC, Wagner FM. First successful use of the new AB5000 protable circulatory support console as bridge to recovery in a case of dilated cardiomyopathy. Int J Artif Organs. 2010;33:824–7.PubMed

19.

Anderson M, Smedira N, Samuels L, Madani M, Naka Y, Acker M, Hout M, Benali K. Use of the AB5000™ ventricular assist device in cardiogenic shock after acute myocardial infarction. Ann Thorac Surg. 2010;90:706–12.CrossRefPubMed

20.

Slaughter MS, Sobieski MA, Martin M, Dia M, Silver MA. Home discharge experience with the Thoratec TLC-II portable driver. ASAIO J. 2007;53:132–5.CrossRefPubMed

21.

Birks EJ, Tansley PD, Yacoub MH, Bowles CT, Hipkin M, Hardy J, Banner NR, Khaghani A. Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant. 2004;23:964–9.CrossRefPubMed

22.

Hetzer R, Potapov EV, Alexi-Meskishvili V, Weng Y, Miera O, Berger F, Hennig E, Hübler M. Single-center experience with treatment of cardiogenic shock in children by pediatric ventricular assist devices. J Thorac Cardiovasc Surg. 2011;141:616–23.CrossRefPubMed

23.

Fraser CD Jr, Jaquiss RD, Rosenthal DN, Humpl T, Canter CE, Blackstone EH, Naftel DC, Ichord RN, Bomgaars L, Tweddell JS, Massicotte MP, Turrentine MW, Cohen GA, Devaney EJ, Pearce FB, Carberry KE, Kroslowitz R, Almond CS, Berlin Heart Study Investigators. Prospective trial of a pediatric ventricular assist device. N Engl J Med. 2012;367:532–41.CrossRefPubMed

24.

Ziemba EA, John R. Mechanical circulatory support for bridge to decision: which device and when to decide. J Card Surg. 2010;25:425–33.CrossRefPubMed

25.

Loforte A, Montalto A, Ranocchi F, Della Monica PL, Casali G, Lappa A, Contento C, Musumeci F. Levitronix CentriMag third-generation magnetically levitated continuous flow pump as bridge to solution. ASAIO J. 2011;57:247–53.CrossRefPubMed

26.

Mohite PN, Zych B, Popov AF, Sabashnikov A, Sáez DG, Patil NP, Amrani M, Bahrami T, DeRobertis F, Maunz O, Marczin N, Banner NR, Simon AR. CentriMag short-term ventricular assist as a bridge to solution in patients with advanced heart failure: use beyond 30 days. Eur J Cardiothorac Surg. 2013;44:e310–5.CrossRefPubMed

27.

Borisenko O, Wylie G, Payne J, Bjessmo S, Smith J, Firmin R, Yonan N. The cost impact of short-term ventricular assist devices and extracorporeal life support systems therapies on the National Health Service in the UK. Interact Cardiovasc Thorac Surg. 2014;. doi:10.1093/icvts/ivu078.PubMed

28.

Takayama H, Chen JM, Jorde UP, Naka Y. Implantation technique of the CentriMag biventricular assist device allowing ambulatory rehabilitation. Interact Cardiovasc Thorac Surg. 2011;12:110–1.CrossRefPubMed

29.

Kashiwa K, Nishimura T, Saito A, et al. Left heart bypass support with the Rotaflow Centrifugal Pump^® as a bridge to decision and recovery in an adult. J Artif Organs. 2012;25:207–10.CrossRef

30.

Inoue T, Nishimura T, Murakami A, Itatani K, Takaoka T, Kitahori K, Umeki A, Takezoe T, Kashiwa K, Kyo S, Ono M. Left ventricular assist device support with a centrifugal pump for 2 months in a 5-kg child. J Artif Organs. 2011;14:253–6.CrossRefPubMed

31.

Khaliel F, Habeeb WA, Saad E, Kjellman U. Use of Rotaflow pump for left ventricular assist device bridging for 15 weeks. Asian Cardiovasc Thorac Ann. 2014;22:205–7.CrossRefPubMed

32.

Khani-Hanjani A, Loor G, Chamogeorgakis T, Shafii A, Mountis M, Hanna M, Soltesz E, Gonzalez-Stawinski GV. Case series using the ROTAFLOW system as a temporary right ventricular assist device after HeartMate II implantation. ASAIO J. 2013;59:456–60.CrossRefPubMed

33.

Haneya A, Philipp A, Puehler T, Rupprecht L, Kobuch R, Hilker M, Schmid C, Hirt SW. Temporary percutaneous right ventricular support using a centrifugal pump in patients with postoperative acute refractory right ventricular failure after left ventricular assist device implantation. Eur J Cardiothorac Surg. 2012;41:219–23.PubMedCentralCrossRefPubMed

34.

Inoue T, Kitamura T, Torii S, Hanayama N, Oka N, Itatani K, Tomoyasu T, Irisawa Y, Shibata M, Hayashi H, Ono M, Miyaji K. Five-week use of a monopivot centrifugal blood pump as a right ventricular assist device in severe dilated cardiomyopathy. J Artif Organs. 2014;17:95–8.CrossRefPubMed

35.

Idelchik GM, Simpson L, Civitello AB, Loyalka P, Gregoric ID, Delgado R 3rd, Kar B. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant. 2008;27:106–11.CrossRefPubMed

36.

Chamogeorgakis T, Rafael A, Shafii AE, Nagpal D, Pokersnik JA, Gonzalez-Stawinski GV. Which is better: a miniaturized percutaneous ventricular assist device or extracorporeal membrane oxygenation for patients with cardiogenic shock? ASAIO J. 2013;59:607–11.CrossRefPubMed

37.

Biefer HR, Sündermann SH, Emmert MY, Hasenclever P, Lachat ML, Falk V, Wilhelm MJ. Experience with a “Hotline” Service for outpatients on a ventricular assist device. Thorac Cardiovasc Surg. 2013;. doi:10.1055/s-0033-1351352.PubMed

38.

Nishimura T, Kyo S, Sato T, Sekiguchi A. Out of hospital program for the patient with an extracorporeal ventricular assist device. Clin Eng. 2008;19:623–7.

39.

Gon S, Suematsu Y, Morizumi S, Shimizu T. Experience of a patient with an extracorporeal ventricular assist system who participated in a sleepover program. J Artif Organs. 2011;14:257–60.CrossRefPubMed

40.

Kawata M, Nishimura T, Hoshino Y, et al. Negative pressure wound therapy for left ventricular assist device-related mediastinitis: two case reports. J Artif Organs. 2011;14:159–62.CrossRefPubMed

41.

Kimura M, Nishimura T, Kinoshita O, Okada S, Inafuku H, Kyo S, Ono M. Successful treatment of pump pocket infection after left ventricular assist device implantation by negative pressure wound therapy and omental transposition. Ann Thorac Cardiovasc Surg. 2013;. doi:10.5761/atcs.cr.12.02192.

42.

Holman WL, Kirklin JK, Naftel DC, Kormos RL, Desvign-Nickens P, Camacho MT, Ascheim DD. Infection after implantation of pulsatile mechanical circulatory support devices. J Thorac Cardiovasc Surg. 2010;139:1632–6.CrossRefPubMed

43.

Inoue T, Nishimura T, Murakami A, Kinoshita O, Kyo S, Ono M. Four-year paracorporeal left ventricular assist device (LVAD) support for heart failure after Rastelli operation. J Artif Organs. 2013;16:501–3.CrossRefPubMed

44.

Masuoka A, Katogi T, Iwazaki M, Kobayashi T, Nishimura T, Kyo S. Bridge to transplantation with a Toyobo-NCVC left ventricular assist device in a 3-year-old girl. Gen Thorac Cardiovasc Surg. 2008;56:357–60.CrossRefPubMed

45.

Matsumiya G, Saitoh S, Sakata Y, Sawa Y. Myocardial recovery by mechanical unloading with left ventricular assist system. Circ J. 2009;73:1386–92.CrossRefPubMed

46.

Müller J, Wallukat G, Weng YG, Dandel M, Spiegelsberger S, Semrau S, Brandes K, Theodoridis V, Loebe M, Meyer R, Hetzer R. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997;96:542–9.CrossRefPubMed

47.

Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, Banner NR, Khaghani A, Yacoub MH. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med. 2006;355:1873–84.CrossRefPubMed

48.

Nishimura T, Kyo S. High-dose carvedilol therapy for mechanical circulatory assisted patients. J Artif Organs. 2010;13:88–91.CrossRefPubMed

49.

Nishimura T, Kyo S. Triple-site pacing: a new supported therapy approach for bridge to recovery with a left ventricular assist system in a patient with idiopathic dilated cardiomyopathy. J Artif Organs. 2010;13:54–7.CrossRefPubMed

50.

Matsumiya G, Monta O, Fukushima N, Sawa Y, Funatsu T, Toda K, Matsuda H. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy? J Thorac Cardiovasc Surg. 2005;130:699–704.CrossRefPubMed

51.

Imamura T, Kinugawa K, Hatano M, Fujino T, Muraoka H, Inaba T, Maki H, Kagami Y, Endo M, Kinoshita O, Nawata K, Kyo S, Ono M. Preoperative beta-blocker treatment is a key for deciding left ventricular assist device implantation strategy as a bridge to recovery. J Artif Organs. 2014;17:23–32.CrossRefPubMed

52.

Yoshioka D, Sakaguchi T, Saito S, Miyagawa S, Nishi H, Yoshikawa Y, Fukushima S, Ueno T, Kuratani T, Sawa Y. Initial experience of conversion of Toyobo paracorporeal left ventricular assist device to DuraHeart left ventricular assist device. Circ J. 2011;76:372–6.CrossRefPubMed

53.

Riebandt J, Haberl T, Mahr S, Laufer G, Rajek A, Steinlechner B, Schima H, Zimpfer D. Preoperative patient optimization using extracorporeal life support improves outcomes of INTERMACS level I patients receiving a permanent ventricular assist device. Eur J Cardiothorac Surg. 2014;. doi:10.1093/ejcts/ezu093.

54.

Takayama H, Truby L, Koekort M, Uriel N, Colombo P, Mancini DM, Jorde UP, Naka Y. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. J Heart Lung Transplant. 2013;32:106–11.CrossRefPubMed

55.

Shiga T, Kinugawa K, Imamura T, Kato N, Endo M, Inaba T, Maki H, Hatano M, Yao A, Nishimura T, Hirata Y, Kyo S, Ono M, Nagai R. Combination evaluation of preoperative risk indices predicts requirement of biventricular assist device. Circ J. 2012;76:2785–91.CrossRefPubMed

56.

Saito S, Sakaguchi T, Miyagawa S, Nishi H, Yoshikawa Y, Fukushima S, Daimon T, Sawa Y. Recovery of right heart function with temporary right ventricular assist using a centrifugal pump in patients with severe biventricular failure. J Heart Lung Transplant. 2012;31:858–64.CrossRefPubMed

57.

Loforte A, Stepanenko A, Potapov EV, Musumeci F, Dranishnikov N, Schweiger M, Montalto A, Pasic M, Weng Y, Dandel M, Siniawski H, Kukucka M, Krabatsch T, Hetzer R. Temporary right ventricular mechanical support in high-risk left ventricular assist device recipients versus permanent biventricular or total artificial heart support. Artif Organs. 2013;37:523–30.CrossRefPubMed

58.

Lazar JF, Swartz MF, Schiralli MP, Schneider M, Pisula B, Hallinan W, Hicks GL Jr, Massey HT. Survival after left ventricular assist device with and without temporary right ventricular support. Ann Thorac Surg. 2013;96:2155–9.CrossRefPubMed

59.

Saito S, Sakaguchi T, Sawa Y. Clinical report of long-term support with dual Jarvik 2000 biventricular assist device. J Heart Lung Transplant. 2011;30:845–7.CrossRefPubMed

60.

Komagamine M, Nishinaka T, Iwata Y, Tsukui Y, Saito S, Yamazaki K. Clinical outcomes of pediatric ventricular assist device implantation: a single-institute report from Japan. Int J Artif Organs. 2013;36:887–91.PubMed

61.

Imamura T, Kinugawa K, Shiga T, Endo M, Kato N, Inaba T, Maki H, Hatano M, Yao A, Nishimura T, Hirata Y, Kyo S, Ono M, Nagai R. Novel risk scoring system with preoperative objective parameters gives a good prediction of 1-year mortality in patients with a left ventricular assist device. Circ J. 2012;76:1895–903.CrossRefPubMed

62.

Shiga T, Kinugawa K, Hatano M, Yao A, Nishimura T, Endo M, Kato N, Hirata Y, Kyo S, Ono M, Nagai R. Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation. Circ J. 2011;75:121–8.CrossRefPubMed

63.

Imamura T, Kinugawa K, Shiga T, Kato N, Endo M, Inaba T, Maki H, Hatano M, Yao A, Hirata Y, Akahane M, Nishimura T, Kyo S, Ono M, Nagai R. How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients? J Artif Organs. 2012;15:395–8.CrossRefPubMed

64.

Russell SD, Rogers JG, Milano CA, Dyke DB, Pagani FD, Aranda JM, Klodell CT Jr, Boyle AJ, John R, Chen L, Massey HT, Farrar DJ, Conte JV, HeartMate II Clinical Investigators. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation. 2009;120:2352–7.CrossRefPubMed

65.

Teuteberg JJ, Stewart GC, Jessup M, Kormos RL, Sun B, Frazier OH, Naftel DC, Stevenson LW. Implant strategies change over time and impact outcomes: insights from the INTERMACS (interagency registry for mechanically assisted circulatory support. JACC Heart Fail. 2013;1:369–78.CrossRefPubMed

66.

Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Timothy Baldwin J, Young JB. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013;32:141–56.CrossRefPubMed

67.

Grady KL, Naftel D, Stevenson L, Dew MA, Weidner G, Pagani FD, Kirklin JK, Myers S, Baldwin T, Young J. Overall quality of life improves to similar levels after mechanical circulatory support regardless of severity of heart failure before implantation. J Heart Lung Transplant. 2014;33:412–21.CrossRefPubMed

Title: Current status of extracorporeal ventricular assist devices in Japan
Author: Takashi Nishimura
Publication date: 01-09-2014
Publisher: Springer Japan
Published in: Journal of Artificial Organs / Issue 3/2014
Print ISSN: 1434-7229
Electronic ISSN: 1619-0904
DOI: https://doi.org/10.1007/s10047-014-0779-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Current status of extracorporeal ventricular assist devices in Japan

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Shrinkage temperature and anti-calcification property of triglycidylamine-crosslinked autologous tissue

Cardiac energetics analysis after aortic valve replacement with 16-mm ATS mechanical valve

Operative modification for the prevention of device-related infection during NIPRO extracorporeal left ventricular assist device implantation

Acute respiratory distress syndrome (ARDS) treated successfully by veno-venous extracorporeal membrane oxygenation (ECMO) in a nearly drowned patient

Early outcomes of extra-thoracic debranching thoracic endovascular aortic repair for distal aortic arch disease

Electromagnetic interference of implantable cardiac devices from a shoulder massage machine